Get the app
US › Healthcare

Eloxx Pharmaceuticals, Inc. (ELOX)

US · Healthcare · Biotechnology

$12.44-2.81%
Last close · 2026-11-06

Key statistics

Market cap
$51.7M
P/E
3.6
Forward P/E
0.0
P/B
1.12
Book value
$11.50
EPS (TTM)
$3.52
52-week high
$23.40
52-week low
$8.20
50-day MA
$14.91
200-day MA
$14.64
Beta
-169,204.95

Analyst view

Analysts rate Eloxx Pharmaceuticals, Inc. a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $37.50.

Shareholding

Insiders
19.06%
Institutions
74.08%

Largest institutional holders

FundStake
Nantahala Capital Management, LLC23.28%
EcoR1 Capital, LLC11.64%
Siren, L.L.C.11.64%
Samsara BioCapital, LLC11.64%
Aberdeen Group PLC11.64%
Stonepine Capital Management Llc11.56%
Vanguard Capital Management, LLC2.29%
Vanguard Fiduciary Trust Co0.31%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Eloxx Pharmaceuticals, Inc. — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.